These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19293078)

  • 1. Questioning the accuracy of a recent review of osteoporosis medications.
    Kuhl LN; Ettinger B; Rosen CJ; Col NF
    Ann Intern Med; 2009 Mar; 150(6):423-4; author reply 424-5. PubMed ID: 19293078
    [No Abstract]   [Full Text] [Related]  

  • 2. Review of comparative effectiveness of treatments to prevent fractures.
    Black DM; Boonen S; Delmas P; Lyles KW
    Ann Intern Med; 2008 Jun; 148(11):885-6; author reply 887. PubMed ID: 18519940
    [No Abstract]   [Full Text] [Related]  

  • 3. [New bone density conservation agents for osteoporosis under research and development: ED-71].
    Hagino H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():454-8. PubMed ID: 18161148
    [No Abstract]   [Full Text] [Related]  

  • 4. Osteoporosis - new treatments and updates.
    Honig S
    Bull NYU Hosp Jt Dis; 2011; 69(3):253-6. PubMed ID: 22035439
    [No Abstract]   [Full Text] [Related]  

  • 5. Agents for preventing fractures in osteoporosis.
    Matzo M
    Am J Nurs; 2008 Aug; 108(8):73. PubMed ID: 18664769
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis.
    Hodsman A; ; Papaioannou A; ; Ann Cranney ;
    CMAJ; 2006 Jul; 175(1):48. PubMed ID: 16818909
    [No Abstract]   [Full Text] [Related]  

  • 7. Review of comparative effectiveness of treatments to prevent fractures.
    Karis R
    Ann Intern Med; 2008 Jun; 148(11):886; author reply 887. PubMed ID: 18519942
    [No Abstract]   [Full Text] [Related]  

  • 8. [New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].
    Shiraki M
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():447-53. PubMed ID: 18161147
    [No Abstract]   [Full Text] [Related]  

  • 9. Review of comparative effectiveness of treatments to prevent fractures.
    Stock JL; Mershon JL; Schoenfeld MJ
    Ann Intern Med; 2008 Jun; 148(11):885; author reply 887. PubMed ID: 18519941
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of Osteoporosis.
    Cotts KG; Cifu AS
    JAMA; 2018 Mar; 319(10):1040-1041. PubMed ID: 29536084
    [No Abstract]   [Full Text] [Related]  

  • 11. Review of comparative effectiveness of treatments to prevent fractures.
    Rosen H
    Ann Intern Med; 2008 Jun; 148(11):884; author reply 887. PubMed ID: 18519939
    [No Abstract]   [Full Text] [Related]  

  • 12. Review of comparative effectiveness of treatments to prevent fractures.
    Lim LS
    Ann Intern Med; 2008 Jun; 148(11):884-5; author reply 887. PubMed ID: 18519938
    [No Abstract]   [Full Text] [Related]  

  • 13. National Osteoporosis Foundation 2008 Clinician's Guide to Prevention and Treatment of Osteoporosis and the World Health Organization Fracture Risk Assessment Tool (FRAX): what they mean to the bone densitometrist and bone technologist.
    Watts NB; Lewiecki EM; Miller PD; Baim S
    J Clin Densitom; 2008; 11(4):473-7. PubMed ID: 18562228
    [No Abstract]   [Full Text] [Related]  

  • 14. [A-TOP research group/JOINT-02].
    Kuroda T; Ohta H; Shiraki M; Miyakawa N; Hosoi T; Nakamura T; Fukunaga M; Orimo H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():271-4. PubMed ID: 18161118
    [No Abstract]   [Full Text] [Related]  

  • 15. Assessing fracture risk and effects of osteoporosis drugs: bone mineral density and beyond.
    Davison KS; Kendler DL; Ammann P; Bauer DC; Dempster DW; Dian L; Hanley DA; Harris ST; McClung MR; Olszynski WP; Yuen CK
    Am J Med; 2009 Nov; 122(11):992-7. PubMed ID: 19854322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoporosis, fracture risk, and prosthodontic implications.
    Koka S; Salinas TJ; Kennel KA
    Int J Prosthodont; 2009; 22(5):505-6. PubMed ID: 20095203
    [No Abstract]   [Full Text] [Related]  

  • 17. A Perfectly Avoidable Crisis.
    Wallis C
    Sci Am; 2018 Feb; 318(3):24. PubMed ID: 29565337
    [No Abstract]   [Full Text] [Related]  

  • 18. What is the optimal duration of bisphosphonate therapy?
    Ott SM
    Cleve Clin J Med; 2011 Sep; 78(9):619-30. PubMed ID: 21885695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonates for the prevention and treatment of osteoporosis.
    Maraka S; Kennel KA
    BMJ; 2015 Sep; 351():h3783. PubMed ID: 26333528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis - new treatments and updates.
    Honig S
    Bull NYU Hosp Jt Dis; 2010; 68(3):166-70. PubMed ID: 20969546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.